The BET Family of Proteins Targets Moloney Murine Leukemia Virus Integration near Transcription Start Sites

Cell Reports

Volumn 5, Issue 4, 2013, Pages 886-894

  DeRijck, Jan ^a   deKogel, Christine ^a   Demeulemeester, Jonas ^a   Vets, Sofie ^a   ElAshkar, Sara ^a   Malani, Nirav ^b   Bushman, Frederic D ^b   Landuyt, Bart ^c   Husson, Steven J ^c,d   Busschots, Katrien ^a   Gijsbers, Rik ^a   Debyser, Zeger ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODOMAIN AND EXTRATERMINAL PROTEIN; BROMODOMAIN AND EXTRATERMINAL PROTEIN 2; BROMODOMAIN AND EXTRATERMINAL PROTEIN 3; BROMODOMAIN AND EXTRATERMINAL PROTEIN 4; GROWTH FACTOR; INTEGRASE; LENS EPITHELIUM DERIVED GROWTH FACTOR P75; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRAIN 3T3; CHROMATIN; CONTROLLED STUDY; GENETIC TRANSCRIPTION; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSCRIPTION INITIATION SITE; VIRUS DNA CELL DNA INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

MOLONEY MURINE LEUKEMIA VIRUS; MURINE LEUKEMIA VIRUS;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; AZEPINES; CELL LINE; DNA, VIRAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA VIRUS, MURINE; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE; TRIAZOLES; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 84888437641     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.09.040     Document Type: Article

References (39)

1. Berry C., Hannenhalli S., Leipzig J., Bushman F.D. Selection of target sites for mobile DNA integration in the human genome. PLoS Comput. Biol. 2006, 2:e157.
2. Brady T., Lee Y.N., Ronen K., Malani N., Berry C.C., Bieniasz P.D., Bushman F.D. Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev. 2009, 23:633-642.
3. Cattoglio C., Pellin D., Rizzi E., Maruggi G., Corti G., Miselli F., Sartori D., Guffanti A., Di Serio C., Ambrosi A., et al. High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood 2010, 116:5507-5517.
4. Cavazza A., Moiani A., Mavilio F. Mechanisms of retroviral integration and mutagenesis. Hum. Gene Ther. 2013, 24:119-131.
5. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J.L., et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288:669-672.
6. Cherepanov P., Maertens G., Proost P., Devreese B., Van Beeumen J., Engelborghs Y., De Clercq E., Debyser Z. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J.Biol. Chem. 2003, 278:372-381.
7. Ciuffi A., Llano M., Poeschla E., Hoffmann C., Leipzig J., Shinn P., Ecker J.R., Bushman F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 2005, 11:1287-1289.
8. Deichmann A., Hacein-Bey-Abina S., Schmidt M., Garrigue A., Brugman M.H., Hu J., Glimm H., Gyapay G., Prum B., Fraser C.C., et al. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J.Clin. Invest. 2007, 117:2225-2232.
9. Devaiah B.N., Singer D.S. Two faces of brd4: mitotic bookmark and transcriptional lynchpin. Transcription 2013, 4:13-17.
10. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30:207-210.
11. Elis E., Ehrlich M., Prizan-Ravid A., Laham-Karam N., Bacharach E. p12 tethers the murine leukemia virus pre-integration complex to mitotic chromosomes. PLoS Pathog. 2012, 8:e1003103.
12. Felice B., Cattoglio C., Cittaro D., Testa A., Miccio A., Ferrari G., Luzi L., Recchia A., Mavilio F. Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. PLoS ONE 2009, 4:e4571.
13. Filippakopoulos P., Qi J., Picaud S., Shen Y., Smith W.B., Fedorov O., Morse E.M., Keates T., Hickman T.T., Felletar I., et al. Selective inhibition of BET bromodomains. Nature 2010, 468:1067-1073.
14. Gaspar H.B., Parsley K.L., Howe S., King D., Gilmour K.C., Sinclair J., Brouns G., Schmidt M., Von Kalle C., Barington T., et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004, 364:2181-2187.
15. Gijsbers R., Ronen K., Vets S., Malani N., De Rijck J., McNeely M., Bushman F.D., Debyser Z. LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol. Ther. 2010, 18:552-560.
16. Hacein-Bey-Abina S., Le Deist F., Carlier F., Bouneaud C., Hue C., De Villartay J.-P., Thrasher A.J., Wulffraat N., Sorensen R., Dupuis-Girod S., et al. Sustained correction of X-linked severe combined immunodeficiency by exvivo gene therapy. N.Engl. J. Med. 2002, 346:1185-1193.
17. Hower V., Evans S.N., Pachter L. Shape-based peak identification for ChIP-Seq. BMC Bioinformatics 2011, 12:15.
18. Kundaje A., Kyriazopoulou-Panagiotopoulou S., Libbrecht M., Smith C.L., Raha D., Winters E.E., Johnson S.M., Snyder M., Batzoglou S., Sidow A. Ubiquitous heterogeneity and asymmetry of the chromatin environment at regulatory elements. Genome Res. 2012, 22:1735-1747.
19. Langmead B., Salzberg S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 2012, 9:357-359.
20. Leinonen R., Sugawara H., Shumway M. The sequence read archive. Nucleic Acids Res. 2011, 39(Database issue):D19-D21. International Nucleotide Sequence Database Collaboration.
21. Leroy G., Chepelev I., Dimaggio P.A., Blanco M.A., Zee B.M., Zhao K., Garcia B.A. Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins. Genome Biol. 2012, 13:R68.
22. Lewinski M.K., Yamashita M., Emerman M., Ciuffi A., Marshall H., Crawford G., Collins F., Shinn P., Leipzig J., Hannenhalli S., et al. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2006, 2:e60.
23. Lin Y.-J., Umehara T., Inoue M., Saito K., Kigawa T., Jang M.-K., Ozato K., Yokoyama S., Padmanabhan B., Güntert P. Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4. Protein Sci. 2008, 17:2174-2179.
24. Llano M., Saenz D.T., Meehan A., Wongthida P., Peretz M., Walker W.H., Teo W., Poeschla E.M. An essential role for LEDGF/p75 in HIV integration. Science 2006, 314:461-464.
25. Mitchell R.S., Beitzel B.F., Schroder A.R.W., Shinn P., Chen H., Berry C.C., Ecker J.R., Bushman F.D. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2004, 2:E234.
26. Natarajan A., Yardimci G.G., Sheffield N.C., Crawford G.E., Ohler U. Predicting cell-type-specific gene expression from regions of open chromatin. Genome Res. 2012, 22:1711-1722.
27. Nicodeme E., Jeffrey K.L., Schaefer U., Beinke S., Dewell S., Chung C.-W., Chandwani R., Marazzi I., Wilson P., Coste H., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-1123.
28. Roth S.L., Malani N., Bushman F.D. Gammaretroviral integration into nucleosomal target DNA invivo. J.Virol. 2011, 85:7393-7401.
29. Santoni F.A., Hartley O., Luban J. Deciphering the code for retroviral integration target site selection. PLoS Comput. Biol. 2010, 6:e1001008.
30. Schneider W.M., Brzezinski J.D., Aiyer S., Malani N., Gyuricza M., Bushman F.D., Roth M.J. Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag. Proc. Natl. Acad. Sci. USA 2013, 110:9487-9492.
31. Schrijvers R., De Rijck J., Demeulemeester J., Adachi N., Vets S., Ronen K., Christ F., Bushman F.D., Debyser Z., Gijsbers R. LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs. PLoS Pathog. 2012, 8:e1002558.
32. Sharma A., Larue R.C., Plumb M.R., Malani N., Male F., Slaughter A., Kessl J.J., Shkriabai N., Coward E., Aiyer S.S., et al. BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc. Natl. Acad. Sci. USA 2013, 110:12036-12041.
33. Shun M.-C., Raghavendra N.K., Vandegraaff N., Daigle J.E., Hughes S., Kellam P., Cherepanov P., Engelman A. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev. 2007, 21:1767-1778.
34. Struhl K., Segal E. Determinants of nucleosome positioning. Nat. Struct. Mol. Biol. 2013, 20:267-273.
35. Studamire B., Goff S.P. Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology 2008, 5:48.
36. Wang G.P., Ciuffi A., Leipzig J., Berry C.C., Bushman F.D. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 2007, 17:1186-1194.
37. Wang G.P., Levine B.L., Binder G.K., Berry C.C., Malani N., McGarrity G., Tebas P., June C.H., Bushman F.D. Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ Tcells. Mol. Ther. 2009, 17:844-850.
38. Wu X., Li Y., Crise B., Burgess S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003, 300:1749-1751.
39. Zhang W., Prakash C., Sum C., Gong Y., Li Y., Kwok J.J.T., Thiessen N., Pettersson S., Jones S.J.M., Knapp S., et al. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ Tcells. J.Biol. Chem. 2012, 287:43137-43155.